Drug Type Monoclonal antibody |
Synonyms anti-cadherin 3 antibody (Perseus), PPMX-T002 |
Target |
Action modulators |
Mechanism CDH3 modulators(Cadherin 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Biliary Tract Neoplasms | Preclinical | Japan | - | |
Ovarian Cancer | Preclinical | Japan | - | |
Solid tumor | Preclinical | Japan | - | |
Squamous Cell Carcinoma of Head and Neck | Preclinical | Japan | - |